Who should administer Talvey (talquetamab), and what medical support must be available?

Talvey (talquetamab) should be initiated and supervised by physicians experienced in treating multiple myeloma and administered by a healthcare professional, with adequately trained medical personnel and appropriate equipment to manage severe reactions, including cytokine release syndrome and neurologic toxicity, including immune effector cell-associated neurotoxicity syndrome.